Companies Dominating the Docosahexaenoic Acid Market
- Koninklijke DSM N.V.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- BASF SE
- Croda International Plc
- Cellana, Inc.
- Far East Microalgae Industries, Co., Ltd.(FEMICO)
- Pelagia AS
- Corbion NV
- JC Biotech Private Limited
- Source Omega LLC
- Shandong Yuexiang Biotechnology Co., Ltd.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of docosahexaenoic acid is estimated at USD 5.25 billion.
The docosahexaenoic acid market size was over USD 4.51 billion in 2024 and is anticipated to cross USD 15.39 billion by 2037, growing at more than 9.9% CAGR during the forecast period i.e., between 2025-2037. Escalating cases of depression and surging risk of preterm births across the globe will boost the market growth.
Asia Pacific industry is predicted to dominate majority revenue share of 42% by 2037, impelled by growing healthcare expenditure in the region.
The major players in the market are Koninklijke DSM N.V., BASF SE, Croda International Plc, Cellana, Inc., Far East Microalgae Industries, Co., Ltd.(FEMICO), Pelagia AS, Corbion NV, JC Biotech Private Limited, Source Omega LLC, Shandong Yuexiang Biotechnology Co., Ltd.
